 SAN DIEGO , June 1, 2022 PRNewswire -- Viracta Therapeutics, Inc. Nasdaq: VIRX, a precision oncology company targeting virus-associated malignancies, today announced that company management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9, 2022, at 1:30 p.m. EDT. A live webcast of the presentation will be available on the Investors section of the Viracta website under Events and Webcasts at 